Navidea Biopharmaceuticals (NAVB) Announces Presentation of Meta-Analysis Results of Lymphoseek® and ACOSOG Radiolabeled Colloid in Head and Neck Cancer
6/12/2013 8:07:28 AM
More...
|
Navidea Biopharmaceuticals (NAVB) Announces Results From Lymphoseek® Study on Accuracy of Lymph Node Detection From Injection Time to Surgery
6/11/2013 9:52:17 AM
More...
|
Navidea Biopharmaceuticals (NAVB) Announces Presentation of Results from Two Lymphoseek® and Radiolabeled Colloid Studies in Lymphatic Mapping for Breast Cancer at SNMMI
6/11/2013 6:44:13 AM
More...
|
Navidea Biopharmaceuticals (NAVB) Announces Data Presentations at 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI)
6/4/2013 7:38:12 AM
More...
|
Navidea Biopharmaceuticals (NAVB) Announces Highlights of Lymphoseek® Data Presented at Joint International Oncology Congress (JIOC)
5/29/2013 8:16:31 AM
More...
|
Navidea Biopharmaceuticals (NAVB) to Present at the Jefferies and Co. 2013 Global Healthcare Conference
5/29/2013 8:02:23 AM
More...
|
Navidea Biopharmaceuticals (NAVB) Announces the Presentation of Lymphoseek® Data at Joint International Oncology Congress (JIOC)
5/22/2013 7:08:16 AM
More...
|
Nordion International Signs Contract Manufacturing Agreement With Navidea Biopharmaceuticals (NAVB)
5/16/2013 11:42:07 AM
More...
|
Navidea Biopharmaceuticals (NAVB) Announces First Quarter 2013 Results
5/8/2013 7:55:04 AM
More...
|
Navidea Biopharmaceuticals (NAVB) to Announce First Quarter 2013 Financial Results Pre-Market on Wednesday, May 8, 2013
5/6/2013 7:06:07 AM
More...
|
|